Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach

Mohammad Reza Dayer1, Maysam Mard-Soltani2, Mohammad Saaid Dayer3

  • 11. Assistant Professor, Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, Iran. mrdayer@scu.ac.ir.

Insights

Type 2 diabetes patients exhibit a hypercoagulable state, increasing vascular risks. Specific coagulation factors like Factor II (FII) are differently induced in diabetics compared to healthy individuals, impacting myocardial complication prognosis.

Area of Science:

  • Cardiovascular research
  • Hematology
  • Endocrinology

Background:

  • Type 2 diabetes mellitus (T2DM) patients are highly susceptible to vascular abnormalities and myocardial disease.
  • A hypercoagulable state is implicated in the molecular events leading to these complications.
  • Lack of consensus exists regarding the definition and initiating factors of the hypercoagulable state in T2DM.

Purpose of the Study:

  • To investigate the interrelations between coagulation factors and pathogenic events in T2DM.
  • To identify the initiating factors of the hypercoagulable state in diabetic and healthy individuals.
  • To elucidate the role of coagulation factor interactions in myocardial complication prognosis.

Main Methods:

  • Path analysis was employed to study interactions between coagulation factors and other related factors.
  • Coagulation factors were experimentally determined in 40 healthy and 40 T2DM subjects.
  • Multivariate regression analysis and path diagrams were utilized for data analysis using SPSS and AMOS software.

Main Results:

  • Factor II (FII) was identified as the primary cause of the hypercoagulable state.
  • In healthy individuals, FII is induced by Factor X (FX) and Factor VIII (FVIII).
  • In diabetic patients, FII induction involves FX, Factor XI (FXI), Factor V (FV), and von Willebrand Factor (VWF) cofactors.

Conclusions:

  • The relationship between coagulation factors is complex, with significant differences observed in T2DM.
  • Specific cofactor involvement in FII induction varies between diabetic and healthy populations.
  • Understanding these intricate relationships is crucial for determining the prognosis of myocardial complications in T2DM.
Abstract

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
16.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K